424 related articles for article (PubMed ID: 20807574)
21. Estrogen, progesterone, and HER-2 receptor immunostaining in cytology: the effect of varied fixation on human breast cancer cells.
Maleki S; Dorokhova O; Sunkara J; Schlesinger K; Suhrland M; Oktay MH
Diagn Cytopathol; 2013 Oct; 41(10):864-70. PubMed ID: 23447357
[TBL] [Abstract][Full Text] [Related]
22. Effective application of the methanol-based PreservCyt(™) fixative and the Cellient(™) automated cell block processor to diagnostic cytopathology, immunocytochemistry, and molecular biology.
van Hemel BM; Suurmeijer AJ
Diagn Cytopathol; 2013 Aug; 41(8):734-41. PubMed ID: 23444168
[TBL] [Abstract][Full Text] [Related]
23. Nucleic acid quantity and quality from paraffin blocks: defining optimal fixation, processing and DNA/RNA extraction techniques.
Turashvili G; Yang W; McKinney S; Kalloger S; Gale N; Ng Y; Chow K; Bell L; Lorette J; Carrier M; Luk M; Aparicio S; Huntsman D; Yip S
Exp Mol Pathol; 2012 Feb; 92(1):33-43. PubMed ID: 21963600
[TBL] [Abstract][Full Text] [Related]
24. Determination of Her-2/Neu status in breast carcinoma: comparative analysis of immunohistochemistry and fluorescent in situ hybridization.
Jimenez RE; Wallis T; Tabasczka P; Visscher DW
Mod Pathol; 2000 Jan; 13(1):37-45. PubMed ID: 10658908
[TBL] [Abstract][Full Text] [Related]
25. The effects of glyoxal fixation on the histological evaluation of breast specimens.
Umlas J; Tulecke M
Hum Pathol; 2004 Sep; 35(9):1058-62. PubMed ID: 15343506
[TBL] [Abstract][Full Text] [Related]
26. The effect of 96-hour formalin fixation on the immunohistochemical evaluation of estrogen receptor, progesterone receptor, and HER2 expression in invasive breast carcinoma.
Yildiz-Aktas IZ; Dabbs DJ; Cooper KL; Chivukula M; McManus K; Bhargava R
Am J Clin Pathol; 2012 May; 137(5):691-8. PubMed ID: 22523206
[TBL] [Abstract][Full Text] [Related]
27. Effects of fixative and fixation protocols on assessment of Her-2/neu oncogene amplification status by fluorescence in situ hybridization.
Willmore-Payne C; Metzger K; Layfield LJ
Appl Immunohistochem Mol Morphol; 2007 Mar; 15(1):84-7. PubMed ID: 17536313
[TBL] [Abstract][Full Text] [Related]
28. Establishment of the Australian in situ hybridization program for the assessment of HER2 amplification in breast cancer: a model for the introduction of new biomarkers into clinical practice.
Farshid G; Armes JE; Bell R; Cummings M; Fox S; Francis G; Haswell M; Morey A; McCue G; Raymond W; Robbins P; Bilous M
Diagn Mol Pathol; 2010 Dec; 19(4):187-93. PubMed ID: 21052003
[TBL] [Abstract][Full Text] [Related]
29. Delay to formalin fixation 'cold ischemia time': effect on ERBB2 detection by in-situ hybridization and immunohistochemistry.
Portier BP; Wang Z; Downs-Kelly E; Rowe JJ; Patil D; Lanigan C; Budd GT; Hicks DG; Rimm DL; Tubbs RR
Mod Pathol; 2013 Jan; 26(1):1-9. PubMed ID: 22899285
[TBL] [Abstract][Full Text] [Related]
30. [Pre-analytical stage for biomarker assessment in breast cancer: 2014 update of the GEFPICS' guidelines in France].
MacGrogan G; Mathieu MC; Poulet B; Penault-Llorca F; Vincent-Salomon A; Roger P; Treilleux I; Valent A; Antoine M; Becette V; Bor C; Brabencova E; Charafe-Jauffret E; Chenard MP; Dauplat MM; Delrée P; Devouassoux M; Fiche M; Fondrevelle ME; Fridman V; Garbar C; Genin P; Ghnassia JP; Haudebourg J; Laberge-Le Couteulx S; Loussouarn D; Maran-Gonzalez A; Marcy M; Michenet P; Sagan C; Trassard M; Verriele V; Arnould L; Lacroix-Triki M;
Ann Pathol; 2014 Oct; 34(5):366-72. PubMed ID: 25439989
[TBL] [Abstract][Full Text] [Related]
31. Determination of HER2 gene amplification by chromogenic in situ hybridization (CISH) in archival breast carcinoma.
Zhao J; Wu R; Au A; Marquez A; Yu Y; Shi Z
Mod Pathol; 2002 Jun; 15(6):657-65. PubMed ID: 12065780
[TBL] [Abstract][Full Text] [Related]
32. Simultaneous visualization and cell-specific confirmation of RNA and protein in the mouse retina.
Stempel AJ; Morgans CW; Stout JT; Appukuttan B
Mol Vis; 2014; 20():1366-73. PubMed ID: 25352743
[TBL] [Abstract][Full Text] [Related]
33. Delay to formalin fixation effect on HER2 test in breast cancer by dual-color silver-enhanced in situ hybridization (Dual-ISH).
Khoury T; Liu Q; Liu S
Appl Immunohistochem Mol Morphol; 2014 Oct; 22(9):688-95. PubMed ID: 24992176
[TBL] [Abstract][Full Text] [Related]
34. Honey as a substitute for formalin?
Ozkan N; Salva E; Cakalağaoğlu F; Tüzüner B
Biotech Histochem; 2012 Feb; 87(2):148-53. PubMed ID: 21859382
[TBL] [Abstract][Full Text] [Related]
35. Protocol for HER2 FISH Using a Non-cross-linking, Formalin-free Tissue Fixative to Combine Advantages of Cryo-preservation and Formalin Fixation.
Loibner M; Oberauner-Wappis L; Viertler C; Groelz D; Zatloukal K
J Vis Exp; 2017 Dec; (130):. PubMed ID: 29364207
[TBL] [Abstract][Full Text] [Related]
36. The effect of delay in fixation, different fixatives, and duration of fixation in estrogen and progesterone receptor results in breast carcinoma.
Apple S; Pucci R; Lowe AC; Shintaku I; Shapourifar-Tehrani S; Moatamed N
Am J Clin Pathol; 2011 Apr; 135(4):592-8. PubMed ID: 21411782
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of automated silver-enhanced in situ hybridization (SISH) for detection of HER2 gene amplification in breast carcinoma excision and core biopsy specimens.
Shousha S; Peston D; Amo-Takyi B; Morgan M; Jasani B
Histopathology; 2009 Jan; 54(2):248-53. PubMed ID: 19207950
[TBL] [Abstract][Full Text] [Related]
38. Assessment of the Impact of Alternative Fixatives on HER2 Detection in Breast Cancer and Gastric Cancer Tumor Specimens.
Feng W; Inoue R; Kuwata T; Niikura N; Fujii S; Kumaki N; Honda K; Xu LA; Goetz A; Gaule P; Cogswell J; Rimm DL; McGee R
Appl Immunohistochem Mol Morphol; 2023 May-Jun 01; 31(5):339-345. PubMed ID: 37093713
[TBL] [Abstract][Full Text] [Related]
39. Dual-colour chromogenic in-situ hybridization is a potential alternative to fluorescence in-situ hybridization in HER2 testing.
Hwang CC; Pintye M; Chang LC; Chen HY; Yeh KY; Chein HP; Lee N; Chen JR
Histopathology; 2011 Nov; 59(5):984-92. PubMed ID: 22092410
[TBL] [Abstract][Full Text] [Related]
40. Fixation time does not affect expression of HER2/neu: a pilot study.
Ibarra JA; Rogers LW
Am J Clin Pathol; 2010 Oct; 134(4):594-6. PubMed ID: 20855640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
